Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Casma Therapeutics

- PMLiVE

EU concludes discussions with Moderna for COVID-19 vaccine

Biotech company on the verge on finalising supply deal

- PMLiVE

AI: the smart money is on the smart thinking

Looking at the three key areas where AI is being applied: drug discovery, clinical decision-making and clinical trials

Artificial Intelligence in Digital Therapeutics

Leo Grady, CEO of Paige.AI uncovers what it has been like being a pioneer in the digital therapeutic space and the many challenges that come with bringing AI technology to market....

Impetus Digital

- PMLiVE

Moderna looks to price COVID-19 vaccine at $50-$60 per course

Shines spotlight on pricing strategies for potential vaccines

- PMLiVE

Moderna’s COVID-19 vaccine enters pivotal phase 3 trial

Large-scale study will evaluate vaccine in 30,000 participants

The Uptake of Digital Technologies in Healthcare

In this Fireside Chat, Natalie Yeadon sat down with Anand Iyer, Chief Strategy Officer at Welldoc and discussed a myriad of different topics, including AI and MR in healthcare and...

Impetus Digital

- PMLiVE

Merck, Bayer get FDA priority review for heart failure drug

Target action date set for January 2021

- PMLiVE

Moderna’s COVID-19 vaccine produces immune response in early trial

Antibodies observed in all participants tested

- PMLiVE

Merck expands partnership with Zymeworks for multispecific antibodies

New licence agreement builds on existing collaboration

- PMLiVE

Moderna clashes with US scientists over pivotal COVID-19 vaccine trials

Delays allegedly resulting from a lack of cooperation

- PMLiVE

Pfizer eyes 20-strain Prevnar filing this year, after phase 3 win

New-generation shot could protect franchise from rival Merck & Co

- PMLiVE

First patients dosed with Moderna’s COVID-19 vaccine

More pharma players also join vaccine development efforts

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links